These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9185633)

  • 1. Late myocardial ischemic events after saphenous vein graft intervention--importance of initially "nonsignificant" vein graft lesions.
    Ellis SG; Brener SJ; DeLuca S; Tuzcu EM; Raymond RE; Whitlow PL; Topol EJ
    Am J Cardiol; 1997 Jun; 79(11):1460-4. PubMed ID: 9185633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procedural results and intermediate clinical outcomes after multiple saphenous vein graft stenting.
    Bhargava B; Kornowski R; Mehran R; Kent KM; Hong MK; Lansky AJ; Waksman R; Pichard AD; Satler LF; Leon MB
    J Am Coll Cardiol; 2000 Feb; 35(2):389-97. PubMed ID: 10676686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary percutaneous treatment of saphenous vein graft stenosis: immediate and late outcomes.
    Nishida T; Colombo A; Briguori C; Adamian M; Finci L; Albiero R; Ferraro M; Di Mario C
    J Invasive Cardiol; 2000 Oct; 12(10):505-12. PubMed ID: 11022209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of aorto-saphenous vein bypass narrowing late after coronary artery bypass grafting.
    Rodés-Cabau J; Facta A; Larose E; DeLarochellière R; Déry JP; Nguyen CM; Roy L; Proulx G; Gleeton O; Barbeau G; Noël B; Rouleau J; Boudreault JR; Bertrand OF
    Am J Cardiol; 2007 Aug; 100(4):640-5. PubMed ID: 17697821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of saphenous vein graft radiographic markers on clinical events and angiographic parameters.
    Olenchock SA; Karmpaliotis D; Gibson WJ; Murphy SA; Southard MC; Ciaglo L; Buros J; Mack MJ; Alexander JH; Harrington RA; Califf RM; Kouchoukos NT; Ferguson TB; Gibson CM
    Ann Thorac Surg; 2008 Feb; 85(2):520-4. PubMed ID: 18222256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (stenting of saphenous vein grafts) trial.
    Lichtenwalter C; de Lemos JA; Roesle M; Obel O; Holper EM; Haagen D; Saeed B; Iturbe JM; Shunk K; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S; Brilakis ES
    JACC Cardiovasc Interv; 2009 Sep; 2(9):855-60. PubMed ID: 19778774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term (4- to 6-year) outcome of Palmaz-Schatz stenting: paucity of late clinical stent-related problems.
    Laham RJ; Carrozza JP; Berger C; Cohen DJ; Kuntz RE; Baim DS
    J Am Coll Cardiol; 1996 Oct; 28(4):820-6. PubMed ID: 8837554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous Coronary Intervention of Saphenous Vein Graft.
    Redfors B; Généreux P; Witzenbichler B; McAndrew T; Diamond J; Huang X; Maehara A; Weisz G; Mehran R; Kirtane AJ; Stone GW
    Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28495896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short- and long-term outcome of narrowed saphenous vein bypass graft: a comparison of Palmaz-Schatz stent, directional coronary atherectomy, and balloon angioplasty.
    Waksman R; Weintraub WS; Ghazzal Z; Scott NA; Shen Y; King SB; Douglas JS
    Am Heart J; 1997 Aug; 134(2 Pt 1):274-81. PubMed ID: 9313608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of long-term outcome after stent implantation in a saphenous vein graft.
    Le May MR; Labinaz M; Marquis JF; Laramée LA; O'Brien ER; Williams WL; Jelley JL; Woodend K; Higginson LA
    Am J Cardiol; 1999 Mar; 83(5):681-6. PubMed ID: 10080418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sealing Intermediate Nonobstructive Coronary Saphenous Vein Graft Lesions With Drug-Eluting Stents as a New Approach to Reducing Cardiac Events: A Randomized Controlled Trial.
    Rodés-Cabau J; Jolly SS; Cairns J; Mansour S; L'Allier PL; Teefy PJ; Graham JJ; Le May MR; Cantor WJ; Wood D; Balasubramanian K; DeLarochellière R; Dzavik V;
    Circ Cardiovasc Interv; 2016 Nov; 9(11):. PubMed ID: 27815344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes after implantation of the TAXUS paclitaxel-eluting stent in saphenous vein graft lesions: results from the ARRIVE (TAXUS Peri-Approval Registry: A Multicenter Safety Surveillance) program.
    Brilakis ES; Lasala JM; Cox DA; Berger PB; Bowman TS; Starzyk RM; Dawkins KD
    JACC Cardiovasc Interv; 2010 Jul; 3(7):742-50. PubMed ID: 20650436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and outcomes of intermediate saphenous vein graft lesions: findings from the stenting of saphenous vein grafts randomized-controlled trial.
    Abdel-Karim AR; Da Silva M; Lichtenwalter C; de Lemos JA; Obel O; Addo T; Roesle M; Haagen D; Rangan BV; Makke L; Jeroudi OM; Raghunathan D; Saeed B; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S; Brilakis ES
    Int J Cardiol; 2013 Oct; 168(3):2468-73. PubMed ID: 23561918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From debulking to delivery: sequential use of rotational atherectomy and Guidezilla™ for complex saphenous vein grafts intervention.
    Pellicano M; Floré V; Barbato E; De Bruyne B
    BMC Cardiovasc Disord; 2018 Jun; 18(1):122. PubMed ID: 29921223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of a high risk cohort after stent implantation in saphenous vein grafts.
    Frimerman A; Rechavia E; Eigler N; Payton MR; Makkar R; Litvack F
    J Am Coll Cardiol; 1997 Nov; 30(5):1277-83. PubMed ID: 9350927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery.
    Halabi AR; Alexander JH; Shaw LK; Lorenz TJ; Liao L; Kong DF; Milano CA; Harrington RA; Smith PK
    Am J Cardiol; 2005 Nov; 96(9):1254-9. PubMed ID: 16253593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of hormone therapy in women after coronary bypass surgery. Evidence of differential effect of hormone therapy on angiographic progression of disease in saphenous vein grafts and native coronary arteries.
    Ouyang P; Tardif JC; Herrington DM; Stewart KJ; Thompson PD; Walsh MN; Bennett SK; Heldman AW; Tayback MA; Wang NY;
    Atherosclerosis; 2006 Dec; 189(2):375-86. PubMed ID: 16442114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-eluting stenting of saphenous vein graft versus native coronary artery supplying the same myocardial perfusion territory: a pilot retrospective 3-year follow-up.
    Ho PC; Lee AC; Fortuna R
    J Invasive Cardiol; 2012 Oct; 24(10):516-20. PubMed ID: 23043035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial.
    Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Van den Branden F; Van Langenhove G;
    J Am Coll Cardiol; 2007 Jul; 50(3):261-7. PubMed ID: 17631219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and angiographic outcomes after percutaneous recanalization of chronic total saphenous vein graft occlusion using modern techniques.
    Al-Lamee R; Ielasi A; Latib A; Godino C; Ferraro M; Arioli F; Mussardo M; Piraino D; Figini F; Carlino M; Montorfano M; Chieffo A; Colombo A
    Am J Cardiol; 2010 Dec; 106(12):1721-7. PubMed ID: 21126616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.